Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease

Journal of Clinical Oncology

Volumn 24, Issue 1, 2006, Pages 52-58

  Van Trommel, Nienke E ^a   Massuger, Leon F ^a   Schijf, Charles P ^a   Ten Kate Booij, Marianne J ^a   Sweep, Fred C ^a   Thomas, Chris M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; DACTINOMYCIN; METHOTREXATE; ANTINEOPLASTIC ANTIMETABOLITE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HYDATIDIFORM MOLE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MONOTHERAPY; NEOPLASM; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; TROPHOBLASTIC DISEASE; AREA UNDER THE CURVE; BLOOD; DRUG RESISTANCE; MIDDLE AGED; PREGNANCY; TROPHOBLASTIC TUMOR; UTERUS CANCER;

ADOLESCENT; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; AREA UNDER CURVE; CHORIONIC GONADOTROPIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; METHOTREXATE; MIDDLE AGED; PREGNANCY; TROPHOBLASTIC NEOPLASMS; UTERINE NEOPLASMS;

EID: 33644843640     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.3043     Document Type: Article

References (29)

1. Bentley RC: Pathology of gestational trophoblastic disease. Clin Obstet Gynecol 46:513-522, 2003
2. FIGO Oncology Committee: FIGO staging for gestational trophoblastic neoplasia 2000. Int J Gynaecol Obstet 77:285-287, 2002
3. Hancock BW: Staging and classification of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol 17:869-883, 2003
4. Yedema KA, Verheijen RH, Kenemans P, et al: Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve. Am J Obstet Gynecol 168:787-792, 1993
5. Dutch Society for Obstetrics and Gynaecology: Richtlijn Molazwangerschap 1.1 (Guideline Mole Pregnancy 1.1), 2005. http://www.nvog.nl
6. Berkowitz RS, Goldstein DP: Gestational trophoblastic disease. Cancer 76:2079-2085, 1995
7. Bagshawe KD, Lawler SD, Paradinas FJ, et al: Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole. Lancet 335: 1074-1076, 1990
8. Berkowitz RS, Goldstein DP, Bernstein MR: Natural history of partial molar pregnancy. Obstet Gynecol 66:677-681, 1985
9. Goto S, Yamada A, Ishizuka T, et al: Development of postmolar trophoblastic disease after partial molar pregnancy. Gynecol Oncol 48:165-170, 1993
10. Rice LW, Berkowitz RS, Lage JM, et al: Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol 36:358-362, 1990
11. Dutch Society for Obsterics and Gynaecology: Richtlijn Persisterende Trophoblast Ziekte 1.1 (Guideline Persistent Trophoblastic Disease 1.1), 2005. http://www.nvog.nl
12. Ng TY, Wong LC: Diagnosis and management of gestational trophoblastic neoplasia. Best Pract Res Clin Obstet Gynaecol 17:893-903, 2003
13. Osborne R, Gerulath A: What is the best regimen for low-risk gestational trophoblastic neoplasia? A review. J Reprod Med 49:602-616, 2004
14. Lurain JR: Treatment of metastatic gestational trophoblastic tumors, in Hancock BW, Newlands ES, Berkowitz R (eds): Gestational Trophoblastic Disease. London, United Kingdom, Chapman & Hall, 1997, pp 199-209
15. McNeish IA, Strickland S, Holden L, et al: Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 20:1838-1844, 2002
16. Matsui H, Suzuka K, Yamazawa K, et al: Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy. Gynecol Oncol 96:616-620, 2005
17. Sobrero A, Aschele C, Rosso R, et al: Rapid development of resistance to antifolates in vitro: Possible clinical implication. J Natl Cancer Inst 83: 24-28, 1991
18. Moscow JA, Gong M, He R, et al: Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res 55:3790-3794, 1995
19. Gorlick R, Goker E, Trippett T, et al: Intrinsic and acquired resistance to methotrexate in acute leukemia. N Engl J Med 335:1041-1048, 1996
20. Rotmensch J, Rosenshein NB, Block BS: Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar non-metastatic gestational trophoblastic neoplasia. Gynecol Oncol 29:82-86, 1988
21. Shigematsu T, Kamura T, Saito T, et al: Identification of persistent trophoblastic diseases based on a human chorionic gonadotropin regression curve by means of a stepwise piecewise linear regression analysis after the evacuation of uneventful moles. Gynecol Oncol 71:376-380, 1998
22. McNeish IA, Strickland S, Holden L, et al: Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 20:1838-1844, 2002
23. Seckl MJ, Rustin GJ: Late toxicity after therapy of gestational trophoblastic tumors, in Hancock BW, Newlands ES, Berkowitz R, et al (eds): Gestational Trophoblastic Disease (online book). International Society for the Study of Trophoblastic Diseases, 2003, pp 367-379. http://www.isstd.org/gtd/ 20%20word%20 for%20print.pdf
24. Rustin GJ, Newlands ES, Lutz JM, et al: Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol 14:2769-2773, 1996
25. Bower M, Rustin GJ, Newlands ES, et al: Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years. Eur J Cancer 34: 1204-1207, 1998
26. Thomas CM, Segers MF, Houx PC: Comparison of the analytical characteristics and clinical usefulness in tumour monitoring of fifteen hCG(-beta) immunoassay kits. Ann Clin Biochem 22:236-246, 1985
27. Schlaerth JB, Morrow CP, Kletzky OA, et al: Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy. Obstet Gynecol 58:478-482, 1981
28. Behtash N, Ghaemmaghami F, Honar H, et al: Is normal beta-hCG regression curve helpful in the diagnosis of persistent trophoblastic disease? Int J Gynecol Cancer 14:980-983, 2004
29. Steigrad SJ: Epidemiology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol 17:837-847, 2003